SYRE
Spyre Therapeutics, Inc.
+1.41 (+1.54%)92.58USD357K成交股數8.2B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 39 · 1.6B · 10 |
| 其中 10b5-1 計畫賣出 | 33 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 1.6B |
| 近 180 天 淨額 | −1.6B |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 | 09-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 18.2K | 89.35 | 1.6M | 79.8K | SEC |
| 2026-09-02 | 09-03 | King-Jones Heidy | See Remarks | M 選擇權執行 | 400 | 14.50 | 6K | 3.2K | SEC |
| 2026-09-02 | 09-03 | King-Jones Heidy | See Remarks | S 公開市場賣出(10b5-1) | 400 | 90.00 | 36K | 2.8K | SEC |
| 2026-09-01 | 09-03 | King-Jones Heidy | See Remarks | S 公開市場賣出(10b5-1) | 16.5K | 87.20 | 1.4M | 9.5K | SEC |
| 2026-09-01 | 09-03 | King-Jones Heidy | See Remarks | S 公開市場賣出(10b5-1) | 400 | 89.38 | 36K | 2.8K | SEC |
| 2026-09-01 | 09-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.4K | 87.11 | 382K | 100K | SEC |
| 2026-09-01 | 09-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 200 | 89.04 | 18K | 98.0K | SEC |
| 2026-09-01 | 09-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.0K | 88.03 | 177K | 98.2K | SEC |
| 2026-09-01 | 09-03 | King-Jones Heidy | See Remarks | M 選擇權執行 | 28.0K | 14.50 | 406K | 30.8K | SEC |
| 2026-09-01 | 09-03 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 7.5K | 14.50 | 109K | 105K | SEC |
| 2026-09-01 | 09-03 | King-Jones Heidy | See Remarks | S 公開市場賣出(10b5-1) | 4.8K | 86.40 | 419K | 26.0K | SEC |
| 2026-09-01 | 09-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.5K | 86.36 | 216K | 565K | SEC |
| 2026-09-01 | 09-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 8.4K | 87.15 | 732K | 557K | SEC |
| 2026-09-01 | 09-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 400 | 89.07 | 36K | 553K | SEC |
| 2026-09-01 | 09-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.7K | 88.06 | 326K | 553K | SEC |
| 2026-09-01 | 09-03 | King-Jones Heidy | See Remarks | S 公開市場賣出(10b5-1) | 6.2K | 88.17 | 547K | 3.2K | SEC |
| 2026-09-01 | 09-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 900 | 86.25 | 78K | 105K | SEC |
| 2026-08-07 | 08-10 | Albers Jeffrey W. | Director | S 公開市場賣出(10b5-1) | 8.0K | 104.38 | 835K | 19.4K | SEC |
| 2026-08-07 | 08-10 | Albers Jeffrey W. | Director | S 公開市場賣出(10b5-1) | 5.0K | 104.47 | 522K | 0 | SEC |
| 2026-08-07 | 08-10 | Albers Jeffrey W. | Director | M 選擇權執行 | 5.0K | 10.39 | 52K | 5.0K | SEC |
| 2026-08-07 | 08-10 | Albers Jeffrey W. | Director | S 公開市場賣出(10b5-1) | 10.0K | 104.68 | 1.0M | 9.4K | SEC |
| 2026-08-03 | 08-05 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 16 | 97.46 | 2K | 568K | SEC |
| 2026-08-03 | 08-05 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.3K | 96.30 | 221K | 98.1K | SEC |
| 2026-08-03 | 08-05 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.2K | 95.10 | 681K | 575K | SEC |
| 2026-08-03 | 08-05 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.6K | 95.93 | 541K | 569K | SEC |
| 2026-08-03 | 08-05 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 800 | 93.97 | 75K | 582K | SEC |
| 2026-08-03 | 08-05 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 100 | 97.10 | 10K | 98.0K | SEC |
| 2026-08-03 | 08-05 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 7.5K | 14.50 | 109K | 105K | SEC |
| 2026-08-03 | 08-05 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.4K | 96.82 | 135K | 568K | SEC |
| 2026-08-03 | 08-05 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.1K | 95.21 | 486K | 100K | SEC |
| 2026-07-01 | 07-02 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 6.5K | 87.52 | 569K | 1.8K | SEC |
| 2026-07-01 | 07-02 | Sloan Sheldon | Chief Medical Officer | M 選擇權執行 | 8.3K | 27.46 | 229K | 8.3K | SEC |
| 2026-07-01 | 07-02 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.7K | 88.37 | 152K | 98.0K | SEC |
| 2026-07-01 | 07-02 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 10.2K | 87.44 | 890K | 587K | SEC |
| 2026-07-01 | 07-02 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.8K | 87.55 | 506K | 99.7K | SEC |
| 2026-07-01 | 07-02 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 590 | 88.91 | 52K | 583K | SEC |
| 2026-07-01 | 07-02 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 4.2K | 88.12 | 373K | 583K | SEC |
| 2026-07-01 | 07-02 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.8K | 88.34 | 162K | 0 | SEC |
| 2026-07-01 | 07-02 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 7.5K | 14.50 | 109K | 105K | SEC |
| 2026-06-25 | 06-26 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 15.0K | 14.50 | 218K | 113K | SEC |
| 2026-06-25 | 06-26 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出 | 5.0K | 87.12 | 436K | 108K | SEC |
| 2026-06-25 | 06-26 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出 | 10.0K | 87.14 | 871K | 98.0K | SEC |
| 2026-06-23 | 06-23 | Harwin Peter Evan | Director | C 轉換 | 667K | – | – | 4.7M | SEC |
| 2026-06-23 | 06-23 | Fairmount Funds Management LLC | Director | S 公開市場賣出 | 4.7M | 85.31 | 400M | 0 | SEC |
| 2026-06-23 | 06-23 | Kiselak Tomas | Director | S 公開市場賣出 | 4.7M | 85.31 | 400M | 0 | SEC |
| 2026-06-23 | 06-23 | Kiselak Tomas | Director | C 轉換 | 667K | – | – | 4.7M | SEC |
| 2026-06-23 | 06-23 | Fairmount Funds Management LLC | Director | C 轉換 | 667K | – | – | 4.7M | SEC |
| 2026-06-23 | 06-23 | Fairmount Healthcare Fund II L.P. | Director | S 公開市場賣出 | 4.7M | 85.31 | 400M | 0 | SEC |
| 2026-06-23 | 06-23 | Fairmount Healthcare Fund II L.P. | Director | C 轉換 | 667K | – | – | 4.7M | SEC |
| 2026-06-23 | 06-23 | Harwin Peter Evan | Director | S 公開市場賣出 | 4.7M | 85.31 | 400M | 0 | SEC |
| 2026-06-22 | 06-23 | HENDERSON MICHAEL THOMAS | Director | S 公開市場賣出(10b5-1) | 20.0K | 100.00 | 2.0M | 68.6K | SEC |
| 2026-06-03 | 06-03 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 8.3K | 75.00 | 625K | 0 | SEC |
| 2026-06-03 | 06-03 | Sloan Sheldon | Chief Medical Officer | M 選擇權執行 | 8.3K | 27.46 | 229K | 8.3K | SEC |
| 2026-06-01 | 06-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.8K | 69.75 | 126K | 104K | SEC |
| 2026-06-01 | 06-03 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 7.5K | 14.50 | 109K | 105K | SEC |
| 2026-06-01 | 06-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.3K | 71.38 | 235K | 598K | SEC |
| 2026-06-01 | 06-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 8.1K | 70.50 | 575K | 601K | SEC |
| 2026-06-01 | 06-03 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.6K | 69.40 | 247K | 609K | SEC |
| 2026-06-01 | 06-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 72.06 | 223K | 98.0K | SEC |
| 2026-06-01 | 06-03 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.6K | 70.77 | 184K | 101K | SEC |
| 2026-05-08 | 05-08 | HENDERSON MICHAEL THOMAS | Director | S 公開市場賣出(10b5-1) | 24.8K | 74.76 | 1.9M | 108K | SEC |
| 2026-05-08 | 05-08 | HENDERSON MICHAEL THOMAS | Director | S 公開市場賣出(10b5-1) | 33.5K | 73.72 | 2.5M | 133K | SEC |
| 2026-05-08 | 05-08 | HENDERSON MICHAEL THOMAS | Director | S 公開市場賣出(10b5-1) | 2.4K | 72.57 | 174K | 166K | SEC |
| 2026-05-08 | 05-08 | HENDERSON MICHAEL THOMAS | Director | S 公開市場賣出(10b5-1) | 19.3K | 75.35 | 1.5M | 88.6K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 400 | 75.37 | 30K | 0 | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 10.4K | 73.74 | 764K | 5.5K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 12.8K | 72.94 | 932K | 15.8K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 8.8K | 71.56 | 628K | 28.6K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 21.3K | 69.53 | 1.5M | 57.0K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | M 選擇權執行 | 78.3K | 27.46 | 2.2M | 78.3K | SEC |
| 2026-05-01 | 05-01 | Burrows Scott L | Chief Financial Officer | S 公開市場賣出(10b5-1) | 12.5K | 71.37 | 892K | 98.0K | SEC |
| 2026-05-01 | 05-01 | Burrows Scott L | Chief Financial Officer | M 選擇權執行 | 12.5K | 14.50 | 181K | 110K | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 300 | 74.96 | 22K | 613K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 19.7K | 70.61 | 1.4M | 37.4K | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.7K | 74.23 | 126K | 613K | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.1K | 73.14 | 227K | 615K | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.0K | 71.76 | 72K | 618K | SEC |
| 2026-05-01 | 05-01 | Sloan Sheldon | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.1K | 74.60 | 377K | 400 | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.6K | 70.77 | 255K | 619K | SEC |
| 2026-05-01 | 05-01 | Turtle Cameron | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.3K | 69.54 | 369K | 622K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 13.0M | 1.2B | 新進 | 新進 |
| BlackRock, Inc. | 6.5M | 578M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 4.3M | 383M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 4.3M | 377M | 新進 | 新進 |
| Paradigm Biocapital Advisors LP | 3.8M | 341M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | 306M | 新進 | 新進 |
| STATE STREET CORP | 3.1M | 271M | 新進 | 新進 |
| Venrock Adviser, LLC | 3.0M | 265M | 新進 | 新進 |
| Driehaus Capital Management LLC | 2.8M | 249M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6M | 239M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.3M | 207M | 新進 | 新進 |
| Capital World Investors | 2.3M | 206M | 新進 | 新進 |
| Jupiter Topco LLC | 2.2M | 196M | 新進 | 新進 |
| TCG Crossover Management, LLC | 1.9M | 169M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 1.9M | 168M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.8M | 158M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.7M | 153M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.6M | 140M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.5M | 131M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 1.5M | 131M | 新進 | 新進 |
| Remedium Capital Partners, LLC | 1.5M | 130M | 新進 | 新進 |
| Affinity Asset Advisors, LLC | 1.3M | 114M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.1M | 98.9M | 新進 | 新進 |
| Holocene Advisors, LP | 1.0M | 90.1M | 新進 | 新進 |
| MARSHALL WACE, LLP | 992K | 88.0M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 267 +68 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 267 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 95.8M · 100.0% |
| 合計季末市值 | 8.2B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 11.9M |
|---|---|
| 與上期比 | +0.9% |
| 佔流通股數 | 13.45% |
| 日均成交量 | 1.2M |
| 回補天數 | 9.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 11.9M | +0.9% | 13.45% | 1.2M | 9.7 |
| 2026-08-14 | 11.8M | -3.2% | 13.33% | 737K | 16.0 |
| 2026-07-31 | 12.1M | -2.9% | 13.77% | 899K | 13.5 |
| 2026-07-15 | 12.5M | -8.3% | 14.19% | 1.4M | 9.0 |
| 2026-06-30 | 13.6M | +8.1% | 15.47% | 2.5M | 5.6 |
| 2026-06-15 | 12.6M | -0.1% | 14.31% | 1.2M | 10.8 |
| 2026-05-29 | 12.6M | +1.7% | 14.32% | 816K | 15.5 |
| 2026-05-15 | 12.4M | +1.6% | 14.08% | 1.2M | 10.4 |
| 2026-04-30 | 12.2M | +4.7% | 13.86% | 1.2M | 10.0 |
| 2026-04-15 | 11.7M | +11.8% | 13.24% | 1.6M | 7.4 |
| 2026-03-31 | 10.4M | +4.4% | 11.84% | 909K | 11.5 |
| 2026-03-13 | 10.0M | +0.1% | 11.34% | 715K | 14.0 |
| 2026-02-27 | 10.0M | +1.2% | 11.32% | 804K | 12.4 |
| 2026-02-13 | 9.9M | -1.2% | 11.19% | 663K | 14.9 |
| 2026-01-30 | 10.0M | -0.9% | 11.32% | 492K | 20.3 |
| 2026-01-15 | 10.1M | -13.5% | 11.42% | 725K | 13.9 |
| 2025-12-31 | 11.6M | -1.5% | 13.20% | 828K | 14.1 |
| 2025-12-15 | 11.8M | +5.9% | 13.40% | 852K | 13.9 |
| 2025-11-28 | 11.2M | -10.5% | 12.65% | 611K | 18.3 |
| 2025-11-14 | 12.5M | +0.5% | 14.14% | 618K | 20.2 |
| 2025-10-31 | 12.4M | -7.3% | 14.07% | 1.0M | 11.9 |
| 2025-10-15 | 13.4M | -7.4% | 15.19% | 1.5M | 9.2 |
| 2025-09-30 | 14.5M | +4.9% | 16.40% | 795K | 18.2 |
| 2025-09-15 | 13.8M | -2.2% | 15.63% | 483K | 28.5 |
| 2025-08-29 | 14.1M | +6.8% | 15.98% | 480K | 29.4 |
| 2025-08-15 | 13.2M | +2.4% | 14.96% | 432K | 30.5 |